J
Jose Jessurun
Researcher at Cornell University
Publications - 158
Citations - 9708
Jose Jessurun is an academic researcher from Cornell University. The author has contributed to research in topics: Transplantation & Lung. The author has an hindex of 43, co-authored 152 publications receiving 8630 citations. Previous affiliations of Jose Jessurun include Veterans Health Administration & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.
Kerry L. Donnelly,Coleman Smith,Sarah Jane Schwarzenberg,Jose Jessurun,Mark D. Boldt,Elizabeth J. Parks +5 more
TL;DR: In this article, the authors quantified the biological sources of hepatic and plasma lipoprotein TAG in NAFLD patients, using stable isotopes for four days to label and track serum nonesterified fatty acids (NEFAs), dietary fatty acids, and those derived from the de novo lipogenesis (DNL) pathway, present in liver tissue and lipid TAG.
Journal ArticleDOI
Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based Study
Nancy N. Baxter,Dan J. Virnig,David A. Rothenberger,Arden M. Morris,Jose Jessurun,Beth A Virnig +5 more
TL;DR: The association of demographic variables, particularly patient age and geographic location, with adequate lymph nodes evaluation indicates that local surgical and pathology practice patterns may affect adequacy of lymph node evaluation.
Journal ArticleDOI
Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis.
Audrey J. Lazenby,Audrey J. Lazenby,John H. Yardley,John H. Yardley,Francis M. Giardiello,Francis M. Giardiello,Jose Jessurun,Jose Jessurun,Theodore M. Bayless,Theodore M. Bayless +9 more
TL;DR: The entity "microscopic colitis" shows characteristic histopathology including prominent lymphocytic infiltration of epithelium, and thus, a more appropriate designation isymphocytic colitis, which is readily distinguishable from idiopathic inflammatory bowel disease, acute forms ofcolitis, and normal colorectum.
Journal ArticleDOI
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
Yuling Han,Xiaohua Duan,Xiaohua Duan,Liuliu Yang,Benjamin E. Nilsson-Payant,Pengfei Wang,Fuyu Duan,Xuming Tang,Tomer M. Yaron,Tuo Zhang,Skyler Uhl,Yaron Bram,Chanel Richardson,Jiajun Zhu,Zeping Zhao,David Redmond,Sean Houghton,Duc-Huy T. Nguyen,Dong Xu,Xing Wang,Jose Jessurun,Alain C. Borczuk,Yaoxing Huang,Jared L. Johnson,Yuru Liu,Jenny Xiang,Hui Wang,Lewis C. Cantley,Benjamin R. tenOever,David D. Ho,Fong Cheng Pan,Todd Evans,Huanhuan Joyce Chen,Huanhuan Joyce Chen,Robert E. Schwartz,Shuibing Chen +35 more
TL;DR: This work developed a lung organoid model using human pluripotent stem cells (hPSC-LOs) and performed a high-throughput screen of drugs approved by the FDA and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid and quinacrine dihydrochloride.
Journal Article
Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
TL;DR: This model will be useful for studying the pathogenesis, prevention, and treatment of obliterative bronchiolitis after lung transplantation, and it is demonstrated that this lesion can result from allograft rejection.